Unrelated stem cell transplantation (SCT) following a novel reduced intensity conditioning regimen and mycophenolate mophetil (MMF) plus cyclosporin A (CsA) as graft versus host disease (GVHD) prophylaxis.

被引：0
|
作者：
Lacerda, JF
Martins, C
Carmo, JA
Lourenco, F
Juncal, C
Ligeiro, D
Martinho, A
Lacerda, JMF
机构：
[1] Univ Lisbon, Hosp Santa Maria, Hematol & Bone Marrow Transplantat Serv, P-1699 Lisbon, Portugal
[2] Histocompatibil Ctr, Lisbon, Portugal
[3] Histocompatibil Ctr, Coimbra, Portugal
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5446
引用
收藏
页码：430B / 430B
页数：1
相关论文
共 50 条
  • [11] Impact of adding mycophenolate mofetil (MMF) to cyclosporine (CSA) as prophylaxis for acute graft versus host disease (GVHD) following nonmyeloablative allogeneic peripheral blood stem cell (PBSC) transplantation.
    Chakrabarti, S
    Srinivasan, R
    Geller, N
    Abo-Zena, RA
    Marquesen, M
    Goodwin, R
    Donohue, T
    Dunbar, C
    Young, NS
    Leitman, SF
    Read, EJ
    Bolan, CD
    Barrett, AJ
    Childs, R
    BLOOD, 2002, 100 (11) : 419A - 420A
  • [12] PROPHYLAXIS WITH MYCOPHENOLATE MOFETIL AND CYCLOSPORINE CAN DECREASE THE INCIDENCE OF SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) FROM MATCHED UNRELATED DONORS
    Brissot, E.
    Chevallier, P.
    Delaunay, J.
    Guillaume, T.
    Ayari, S.
    Dubruille, V.
    Mahe, B.
    Le Gouill, S.
    Gastinne, T.
    Blin, N.
    Moreau, P.
    Harousseau, J. L.
    Mohty, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 60 - 60
  • [13] Unrelated stem cell transplantation (SCT) after a reduced intensity, conditioning (RIC) regimen containing 25 mg/kg thymoglobulin (THY): Controllable graft versus host disease (GVHD) contributes to survival benefit.
    Lacerda, J. F.
    Martins, C.
    Lourenco, F.
    Carmo, J. A.
    Juncal, C.
    Oliveira, J. J. G.
    Lacerda, J. M. F.
    BLOOD, 2006, 108 (11) : 439B - 439B
  • [14] Graft Versus Host Disease Prophylaxis with Tacrolimus, Sirolimus and MMF in Patients Undergoing Reduced Intensity Conditioning Allogeneic Transplantation
    Lopez Corral, Lucia
    Blazquez Goni, Cristina
    Perez Lopez, Estefania
    Martin Dominguez, Francisco Manuel
    Cabero Martinez, Almudena
    Rodriguez Torres, Nancy
    Cabrero Calvo, Monica
    Espigado, Ildefonso
    Martin Lopez, Ana Africa
    Parody, Rocio
    Baile Gonzalez, Monica
    Caballero, Teresa
    Cortes-Rodriguez, Maria
    Soria Saldise, Elena
    Avendano Pita, Alejandro
    Alcalde Mellado, Patricia
    Garcia Bacelar, Ana
    Rodriguez Arboli, Eduardo
    Lopez Parra, Miriam
    Francisco Falantes, Jose
    Navarro Bailon, Almudena
    Vazquez Lopez, Lourdes
    Escamilla Gomez, Virginia
    Martin, Fermin Sanchez-Guijo
    Perez-Simon, Jose A.
    BLOOD, 2023, 142
  • [15] UNDER-EXPOSURE TO MYCOPHENOLATE ACID (MPA) AFTER REDUCED-INTENSITY CONDITIONING REGIMEN ALLOGENEIC STEM CELL TRANSPLANTATION (RIC ALLOSCT) USING MYCOPHENOLATE MOFETIL (MMF) PLUS CYCLOSPORINE A (CSA) AS GVHD PROPHYLAXIS IS ASSOCIATED TO HIGH RISK OF GRADE
    Martinez, C.
    Millan, O.
    Rovira, M.
    Fernandez-Aviles, F.
    Suarez-Lledo, M.
    Urbano-Ispizua, A.
    Brunet, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S284 - S284
  • [16] RAPID ENGRAFTMENT AND LOW RATES OF GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING REDUCED INTENSITY CONDITIONING (RIC) WITH FLUDARABINE/BUSULFAN/ATG (FBA) AND STEM CELL TRANSPLANTATION (SCT) USING UNRELATED DONORS (URD)
    Hamdani, M.
    Awan, F. T.
    Elder, P.
    Lin, T. S.
    Andritsos, L.
    Blunn, W.
    Blunn, K. A.
    Devine, S. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 114 - 115
  • [17] Unrelated stem cell transplantation after a reduced intensity conditioning regimen containing high-dose thymoglobulin leads to controllable graft-versus-host disease
    Lacerda, J. F.
    Martins, C.
    Lourenco, F.
    Carmo, J. A.
    Juncal, C.
    Oliveira, J. J. G.
    Lacerda, J. M. F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (04) : 494 - 497
  • [18] A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease
    Miller, KB
    Roberts, TF
    Chan, G
    Schenkein, DP
    Lawrence, D
    Sprague, K
    Gorgun, G
    Relias, V
    Grodman, H
    Mahajan, A
    Foss, F
    BONE MARROW TRANSPLANTATION, 2004, 33 (09) : 881 - 889
  • [19] A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease
    K B Miller
    T F Roberts
    G Chan
    D P Schenkein
    D Lawrence
    K Sprague
    G Gorgun
    V Relias
    H Grodman
    A Mahajan
    F M Foss
    Bone Marrow Transplantation, 2004, 33 : 881 - 889
  • [20] CsA plus MTX plus MMF plus low-dose ATG protocal for GVHD prophylaxis in unrelated donor hematopoietic stem cell transplantation.
    Liu, QF
    Sun, J
    Zhang, Y
    Liu, XL
    Xu, D
    BLOOD, 2003, 102 (11) : 473B - 473B
12345